C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2004
11/18/2004	WO2004099158A1 Monocyclic diazodioxide based bcl-2 protein antagonists
11/18/2004	WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004	WO2004099126A1 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
11/18/2004	WO2004098638A1 Effector cell function inhibitor
11/18/2004	WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004	WO2004098590A1 4-bromo-5- (2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl) eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004098589A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	WO2004078109A3 PROCESS FOR SYNTHESISING USEFUL INTERMEDIATES FOR THE PREPARATION OF ανβ3 RECEPTOR ANTAGONISTS
11/18/2004	WO2004074246A3 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
11/18/2004	US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004	US20040229905 Preparation of risperidone
11/18/2004	US20040229900 Useful in the prophylaxis and in therapy of arrhythmias, in particular atrial and ventricular arrhythmias
11/18/2004	US20040229897 Aid in cytokine biosynthesis
11/18/2004	US20040229895 Tetracyclic benzamide derivatives and methods of use thereof
11/18/2004	US20040229894 Inhibition of human teomerase by a G-quadruplex-interaction compound
11/18/2004	US20040229893 Substituted benzothiazole amide derivatives
11/18/2004	US20040229889 HDAC inhibitor
11/18/2004	US20040229887 Novel imidazopyrimidinyl and imidazopyri dinyl derivatives
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229879 CRF receptor antagonists and methods relating thereto
11/18/2004	US20040229874 5HT7 Antagonists and inverse agonists
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229871 Nitrogen compounds such as 2-(5-(4-Fluoro-benzyloxy)-1,3-dioxo -1,3-dihydro-isoindol-2-yl)-acetamide, used for prophylaxis of Alzheimer's disease; amine oxidase inhibitors
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229868 Heterocyclic compounds, methods for the preparation thereof, and uses thereof
11/18/2004	US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004	US20040229862 Imidazo-benzothiazoles
11/18/2004	US20040229861 CGRP receptor antagonists
11/18/2004	US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004	US20040229847 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/18/2004	US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004	US20040228807 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone
11/18/2004	CA2524625A1 Isoquinoline-3-carboxylic acid amides and pharmaceutical uses thereof
11/18/2004	CA2524624A1 Imidazo and thiazolopyridines as jak3 kinase inhibitors
11/18/2004	CA2524622A1 Substituted-1-phthalazinamines as vr-1 antagonists
11/18/2004	CA2524274A1 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524269A1 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
11/18/2004	CA2524259A1 Imidazopyridine intermediates
11/18/2004	CA2524009A1 Use of effectors of glutaminyl and glutamate cyclases
11/18/2004	CA2523922A1 Azaindole compounds as kinase inhibitors
11/18/2004	CA2523714A1 Substituted carboxylic acids
11/18/2004	CA2521700A1 Piperidinyl- and piperazinyl-alkylcarbamate derivatives, preparation and therapeutic application thereof
11/17/2004	EP1477486A2 Imides as inhibitors of TNF alpha
11/17/2004	EP1477482A1 Novel phenylalanine derivative
11/17/2004	EP1477186A1 Antipruritics
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476448A2 Azabicyclic compounds for the treatment of disease
11/17/2004	EP1476445A1 Tricyclic n-acyl compounds
11/17/2004	EP1476431A1 Tricyclic pyrazole derivatives for the treatment of inflammation
11/17/2004	EP1319006B1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
11/17/2004	EP1317455B9 Process for preparing a substituted imidazopyridine compound
11/17/2004	EP1311508B1 Novel beta-amyloid inhibitors, method for producing the same and the use thereof as medicaments
11/17/2004	EP1289999B1 Antitumoral analogs of et-743
11/17/2004	EP1250340B1 Methods and compounds for inhibiting mrp1
11/17/2004	EP1242413B1 Substituted 1,3,4-oxadiazoles and a method of reducing tnf-alpha levels
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP1082321B1 Heterocyclic derivatives which inhibit factor xa
11/17/2004	CN1547581A 二氮杂萘衍生物 Naphthyridine derivatives
11/17/2004	CN1547472A Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors
11/17/2004	CN1546490A Asymmetric dihydroxyltropine alkaloids , their preparing process and pharmaceutical use
11/17/2004	CN1546489A Process for recovering diazabicyclo olefins
11/17/2004	CN1546473A Aliphatic amino substituted indole quinoline derivatives, their preparation method and pharmaceutical application
11/17/2004	CN1546470A 6-phenylpyridyl-2-amine derivatives
11/17/2004	CN1176086C Process to prepare (5R)-(methylamino)-5,6-dihydro-4H-imidazo [4,5,1-ij]-Quinolin-2(1H)-one
11/16/2004	US6818771 Process for the production of a naphthyridine carboxylic acid derivative (methanesulfonate sesquihydrate)
11/16/2004	US6818654 1,2,3,4-tetrahydroquinoline- or 1,2,3,4-tetrahydro-1,8-naphthyridine-3-carboxylate derivatives; treating infections in fish or mammals
11/16/2004	US6818650 1H-imidazo dimers
11/16/2004	US6818646 1,2,3,4-tetrahydro-2-(5-(2-pyridinyl)-pyrimidin-2-yl)-3-(2,3 -dihydrobenzofuranyl)-9h-pyrrolo-(3,4-b)quinolin-9-one; male erectile dysfunction; sexual disorders
11/16/2004	US6818643 Neurotrophic bicyclic diamides
11/16/2004	US6818641 Arthropodicidal carboxanilides
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818327 Organic electroluminescence device
11/16/2004	US6818149 Ligand and complex for catalytically bleaching a substrate
11/11/2004	WO2004096818A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/11/2004	WO2004096805A2 Lyotropic liquid crystal systems based on sulfonated perylenetetracarboxylic acid dibenzimidazoles
11/11/2004	WO2004096804A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
11/11/2004	WO2004096803A1 Azabicyclononene derivatives
11/11/2004	WO2004096802A2 ANTIBIOTIC TETRAHYDRO-β-CARBOLINE DERIVATIVES
11/11/2004	WO2004096801A1 Cannabinoid receptor ligands and uses thereof
11/11/2004	WO2004096798A2 Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and use of same as chemokine antagonists
11/11/2004	WO2004096220A1 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
11/11/2004	WO2004096139A2 Aza spiro alkane derivatives as inhibitors of metalloproteases
11/11/2004	WO2004096130A2 Inhibitors of akt activity
11/11/2004	WO2004096116A2 Diazabicyclononene derivatives
11/11/2004	WO2004087702A3 Method for the enantioselective preparation of sulphoxide derivatives
11/11/2004	WO2004087053A9 Dipeptidyl peptidase inhibitors
11/11/2004	WO2004078110A3 Fused imizadoles as transforming growth factor (tgf) inhibitors
11/11/2004	WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004	WO2004052919A3 Peptide deformylase inhibitors
11/11/2004	WO2004043337A3 Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
11/11/2004	WO2003097356A9 Camptothecin derivatives and polymeric conjugates thereof
11/11/2004	WO2003077850A3 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors
11/11/2004	US20040225130 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040225111 Therapy for osteoporosis
11/11/2004	US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004	US20040225001 Imidazolyl derivatives as corticotropin releasing factor inhibitors
11/11/2004	US20040224986 Piperidinyl targeting compounds that selectively bind integrins
11/11/2004	US20040224983 Cholecystokinin receptors as modulators to mediate diseases and gastrointestinal disorders

1 ... 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 ... 646